In conclusion, by inviting 21 experienced pathologists to score the Ki67 levels of the same set of IHC slides from 40 ER+ breast cancer specimens, we were able to compare the practicability of the three clinical guidelines (IKWG, NHCC, and NHCCa9) in daily clinical practice. This evidence concerns the gene MKI67 and breast carcinoma.